| 705038 |
FRONTIERS IN ONCOLOGY |
A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma |
2021-06-21 |
10.3389/fonc.2021.612952 |
Ye Zaisheng, Zheng Miao, Zeng Yi, Wei Shenghong, Huang He, Wang Yi, Liu Qinying, Lin Zhitao, Chen Shu, Zheng Qiuhong, Chen Luchuan |
| 705037 |
FRONTIERS IN ONCOLOGY |
The Emerging Role of Extracellular Vesicle-Associated RNAs in the Multiple Myeloma Microenvironment |
2021-06-21 |
10.3389/fonc.2021.689538 |
Khalife Jihane, Sanchez James F., Pichiorri Flavia |
| 705036 |
FRONTIERS IN ONCOLOGY |
PDE2 Inhibits PKA-Mediated Phosphorylation of TFAM to Promote Mitochondrial Ca2+-Induced Colorectal Cancer Growth |
2021-06-21 |
10.3389/fonc.2021.663778 |
Zhao Yilin, Wang Yaya, Zhao Jing, Zhang Zhaohui, Jin Mingpeng, Zhou Feng, Jin Chao, Zhang Jing, Xing Jinliang, Wang Nan, He Xianli, Ren Tingting |
| 705035 |
FRONTIERS IN ONCOLOGY |
Validation of the Clinical Treatment Score Post–Five Years in Breast Cancer Patients for Predicting Late Distant Recurrence: A Single-Center Investigation in Korea |
2021-06-21 |
10.3389/fonc.2021.691277 |
Lee Jun-Hee, Lee Se Kyung, Chae Byung Joo, Yu Jonghan, Lee Jeong Eon, Kim Seok Won, Nam Seok Jin, Ryu Jai Min |
| 705034 |
FRONTIERS IN ONCOLOGY |
Effects of Fibrin Clot Inhibitors and Statins on the Intravesical Bacille Calmette–Guérin Therapy for Bladder Cancer: A Systematic Review and Meta-Analysis |
2021-06-21 |
10.3389/fonc.2021.614041 |
Cai Zhiyong, Hu Jiao, Othmane Belaydi, Li Huihuang, Qiu Dongxu, Yi Zhenglin, Chen Jinbo, Zu Xiongbing |
| 705033 |
FRONTIERS IN ONCOLOGY |
Outcomes and Complications of Aggressive Resection Strategy for Pituitary Adenomas in Knosp Grade 4 With Transsphenoidal Endoscopy |
2021-06-21 |
10.3389/fonc.2021.693063 |
Ouyang Taohui, Zhang Na, Xie Shenhao, Tang Bin, Li Junjun, Xiao Limin, Zhang Fabao, Wu Bowen, Zhou Dongwei, Li Meihua, Hong Tao |
| 705032 |
FRONTIERS IN ONCOLOGY |
Remodeling the Epigenetic Landscape of Cancer—Application Potential of Flavonoids in the Prevention and Treatment of Cancer |
2021-06-21 |
10.3389/fonc.2021.705903 |
Jiang Weiyi, Xia Tingting, Liu Cun, Li Jie, Zhang Wenfeng, Sun Changgang |
| 705031 |
FRONTIERS IN ONCOLOGY |
Development and Validation of a Prognostic Nomogram for Hypopharyngeal Carcinoma |
2021-06-21 |
10.3389/fonc.2021.696952 |
Tian Shu, Li Qin, Li Ruichen, Chen Xinyu, Tao Zhonghua, Gong Hongli, Wang Xiaoshen, Hu Xichun |
| 705030 |
FRONTIERS IN ONCOLOGY |
Image-Guided Peri-Tumoral Radiofrequency Hyperthermia-Enhanced Direct Chemo-Destruction of Hepatic Tumor Margins |
2021-06-21 |
10.3389/fonc.2021.593996 |
Chen Minjiang, Zhang Feng, Song Jingjing, Weng Qiaoyou, Li Peicheng, Li Qiang, Qian Kun, Ji Hongxiu, Pietrini Sean, Ji Jiansong, Yang Xiaoming |
| 705029 |
FRONTIERS IN ONCOLOGY |
Evidence on Efficacy and Safety of Chinese Medicines Combined Western Medicines Treatment for Breast Cancer With Endocrine Therapy |
2021-06-21 |
10.3389/fonc.2021.661925 |
Li Lu, Wang Rongyun, Zhang Aolin, Wang Ling, Ge Qianwen, Liu Yuan, Chen Tianhui, Wang Chi Chiu, Leung Ping Chung, Sun Qiuhua, Fan Xiaohui |
